Error message

The page you requested does not exist. For your convenience, a search was performed using the query Infectious Diseases Vaccines.

Page not found

Search results

  1. Herding Cats 2.0: Business Development for Life Science Companies

    infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson & Johnson Family ... programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His experience includes ... of successful early-stage investments in the rare disease space. He was member of the BOD at Armagen ...

  2. Up and Out- Tips on navigating life science relocation

    expertise driving innovative technologies into the clinic to address unmet needs in infectious disease ... the rapid spread of infectious disease and the growing global threat of antibiotic resistance. Prior ... for infectious diseases, biodefense and cancer. Dr. Hubby is an author on numerous issued and pending patents ...

  3. Up and Out- Tips on navigating life science relocation

    expertise driving innovative technologies into the clinic to address unmet needs in infectious disease ... the rapid spread of infectious disease and the growing global threat of antibiotic resistance. Prior ... for infectious diseases, biodefense and cancer. Dr. Hubby is an author on numerous issued and pending patents ...

  4. Webinar Test

    and developed novel RNA vaccine and antimicrobial platforms to address the rapid spread of infectious disease ... she helped advance a unique RNA-based viral vector to develop vaccines for infectious diseases ... technologies into the clinic to address unmet needs in infectious disease and oncology. Prior to Agenovir, she ...

  5. Webinar Test

    and developed novel RNA vaccine and antimicrobial platforms to address the rapid spread of infectious disease ... she helped advance a unique RNA-based viral vector to develop vaccines for infectious diseases ... technologies into the clinic to address unmet needs in infectious disease and oncology. Prior to Agenovir, she ...

  6. Test

    and developed novel RNA vaccine and antimicrobial platforms to address the rapid spread of infectious disease ... she helped advance a unique RNA-based viral vector to develop vaccines for infectious diseases ... technologies into the clinic to address unmet needs in infectious disease and oncology. Prior to Agenovir, she ...

  7. Test

    and developed novel RNA vaccine and antimicrobial platforms to address the rapid spread of infectious disease ... she helped advance a unique RNA-based viral vector to develop vaccines for infectious diseases ... technologies into the clinic to address unmet needs in infectious disease and oncology. Prior to Agenovir, she ...

  8. Bugs, Drugs & Beyond: Targeting the Microbiome to Transform Healthcare

    on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson ... through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ... with diseases such as Crohn's disease, type 1 diabetes and colorectal cancer. He was also involved ...

  9. Copy of Bugs, Drugs & Beyond: Targeting the Microbiome to Transform Healthcare

    metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson & Johnson ... programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His experience includes ... of the microbial imbalance associated with diseases such as Crohn's disease, type 1 diabetes and colorectal ...

  10. Spotlight on JLABS | February 2016

    for potential drugs in the treatment of cancer, CNS disorders, inflammation and infectious diseases ... of patients with orphan diseases. Our strategy is to search for and license mid- to late-stage molecules ... is a multivalent vaccine targeting the tumor endothelium for the treatment of solid tumors. Batu Biologics has ...

Pages

Share